9999999995-19-000675.txt : 20190412
9999999995-19-000675.hdr.sgml : 20190412
20190412001520
ACCESSION NUMBER: 9999999995-19-000675
CONFORMED SUBMISSION TYPE: EFFECT
PUBLIC DOCUMENT COUNT: 1
FILED AS OF DATE: 20190411
DATE AS OF CHANGE: 20190412
EFFECTIVENESS DATE: 20190411
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: Vaxart, Inc.
CENTRAL INDEX KEY: 0000072444
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 591212264
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: EFFECT
SEC ACT: 1933 Act
SEC FILE NUMBER: 333-229536
FILM NUMBER: 19744852
BUSINESS ADDRESS:
STREET 1: 290 UTAH AVE., SUITE 200
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
BUSINESS PHONE: (650) 550-3500
MAIL ADDRESS:
STREET 1: 290 UTAH AVE., SUITE 200
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
FORMER COMPANY:
FORMER CONFORMED NAME: Aviragen Therapeutics, Inc.
DATE OF NAME CHANGE: 20160413
FORMER COMPANY:
FORMER CONFORMED NAME: Biota Pharmaceuticals, Inc.
DATE OF NAME CHANGE: 20121113
FORMER COMPANY:
FORMER CONFORMED NAME: NABI BIOPHARMACEUTICALS
DATE OF NAME CHANGE: 20100719
EFFECT
1
primary_doc.xml
X0101
EFFECT
33
LIVE
2019-04-11
0001047469-19-002127
POS AM
0000072444
Vaxart, Inc.
333-229536